Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy
CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP
Implementing CIDP Clinical Guidelines: Optimizing Therapy
Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
Burden Beyond the Patient: AAD's Impact on Patients and Caregivers
C. Brendan Montano, MD
Anton P. Porsteinsson, MD
Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development
Mapping the Mind: The Pathophysiology That Drives AAD
Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know
Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD
Caregiver Screening Tools for Agitation in Alzheimer’s Disease
Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review
Proactive Screening: Essential Tools for Diagnosing AAD Quickly
Optimizing Outcomes in AAD in Community PCP and LTC Clinics
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.